Immunoprecise Antibodies Ltd.
13F holders, Q3 2025 (September 30)1holders −23
0new positions
23sold out
$1.75avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Immunoprecise Antibodies Ltd. in their 13F filings, down 23 from Q2 2025. 0 opened new positions and 23 sold out. The largest holder was IFP Advisors, Inc ($18K).
- Company
- Immunoprecise Antibodies Ltd.
- CUSIP
- 45257F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 23 | $4.2M |
All 13F filers, Q2 2025 → Q3 2025: 3,990,486 shares sold, net −3,990,486 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | Reduce -50.0% | 10,000 | $18K |
"% of holder's portfolio" is IMMUNOPRECISE ANTIBODIES LTD's weight in each manager's 13F, not the share of Immunoprecise Antibodies Ltd. the manager owns.